Published in Gene Therapy Weekly, July 21st, 2011
"However, a relative clonal dominance was detected in a patient with ß-thalassemia Major, two years after the subject received genetically modified hematopoietic stem...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.